Related Experiment Video

Updated: Aug 14, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Development of antibodies specific to polyanion-modified platelet factor 4 during treatment with fondaparinux

C Pouplard, C Couvret, S Regina

    Journal of Thrombosis and Haemostasis : JTH
    |December 20, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Microfluidics in Assessing Platelet Function
    06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    Related Experiment Videos

    Last Updated: Aug 14, 2026

    A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
    04:32

    A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

    Published on: June 5, 2019

    Microfluidics in Assessing Platelet Function
    06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory.

    Thrombosis journal·2020

    Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR).

    Anaesthesia, critical care & pain medicine·2018

    [Risk factors for thromboembolic disease in young women-the role of hormones].

    Revue des maladies respiratoires·2018

    Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

    European journal of neurology·2018

    Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.

    Vox sanguinis·2017

    [Neonatal arterial ischemic stroke: Which thrombotic biological risk factors to investigate and which practical consequences?]

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017

    Teclistamab for the treatment of autoantibody-mediated coagulation disorders.

    Journal of thrombosis and haemostasis : JTH·2026

    Teclistamab in relapsed, multi-refractory acquired hemophilia A after failure of anti-CD19 CAR-T cell therapy.

    Journal of thrombosis and haemostasis : JTH·2026

    Intravenous Immunoglobulin (IVIG) use in HIT and efficacy of early IVIG compared to standard of care treatment.

    Journal of thrombosis and haemostasis : JTH·2026

    Conceptualizing the Future of Thromboprophylaxis for Hospitalized Children.

    Journal of thrombosis and haemostasis : JTH·2026

    Mediation of the sex disparity in COVID-19 mortality by arterial and venous thromboembolism: a multicenter cohort study the Dutch COVID & Thrombosis Coalition.

    Journal of thrombosis and haemostasis : JTH·2026

    Perioperative Management of Patients on Factor XI or Factor XIa Inhibitors.

    Journal of thrombosis and haemostasis : JTH·2026

    T cells in systemic lupus erythematosus: biology and clinical value.

    Arthritis & rheumatology (Hoboken, N.J.)·2026

    P2X7R+CD8αβ+ T cells exacerbate postoperative ileus by inducing the loss of enterochromaffin cells.

    iScience·2026

    Incremental prognostic value of pan-immune-inflammation value in conservatively treated acute myocardial infarction: derivation and MIMIC-IV validation.

    Frontiers in cardiovascular medicine·2026

    Hierarchical prompting with reasoning large language models for immune checkpoint inhibitor-associated myocarditis evidence extraction pilot study.

    European heart journal. Digital health·2026

    Comparative Diagnostic Yield of Rapid Immunoassay-Based Tests and Nucleic Acid Testing for Transfusion-Transmissible Infections in a Tertiary Care Setting.

    Cureus·2026

    Atezolizumab-bevacizumab rechallenge after immune checkpoint inhibitor-associated myocarditis in advanced hepatocellular carcinoma: a case report.

    Frontiers in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us